Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Darryl W. Maher"'
Autor:
Darryl W. Maher, Richard Steele, David Langton, Lisa K. C. Pearce, William B Smith, Michael Gold, Marianne Empson, Leon Rozen, Joanne Smart, John B. Ziegler, Mimi L.K. Tang, Constance H. Katelaris
Publikováno v:
Journal of Clinical Immunology. 32:897-906
This phase III, open-label, multi-centre study investigated the efficacy, safety, pharmacokinetics and quality of life impact of Evogam(®), a new chromatographically fractionated 16% subcutaneous immunoglobulin, utilising a 1:1 dose transition ratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da8be67a4197e443267bab147993a418
https://doi.org/10.1007/s10875-011-9641-4
https://doi.org/10.1007/s10875-011-9641-4
Autor:
Karl Bleasel, Robert G Stirling, Darryl W. Maher, Robert J. Heddle, Carolyn Stone, Pravin Hissaria
Publikováno v:
Internal Medicine Journal. 42:252-259
Background and aims: Intragam® 10 NF is the next generation 10% intravenous immunoglobulin with three pathogen reduction steps and a noncarbohydrate stabiliser. This open label, cross-over study in patients with primary immunodeficiency was designed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce9802299c5c8bd454543b07fbc760ee
https://doi.org/10.1111/j.1445-5994.2011.02712.x
https://doi.org/10.1111/j.1445-5994.2011.02712.x
Autor:
John W Wilson, Jeffrey J. Presneill, Darryl W. Maher, John F. Cade, Jonathan Cebon, Paul Waring, Judith E. Layton, Nerina Harley
Publikováno v:
Critical Care Medicine. 28:2344-2354
To define the circulating levels of granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) during critical illness and to determine their relationship to the severity of illness as measured by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10df1bc99251afc3e9d5810983907de5
https://doi.org/10.1097/00003246-200007000-00028
https://doi.org/10.1097/00003246-200007000-00028
Autor:
Russell L. Basser, Richard M. Fox, Jonathan Cebon, John S. Hill, Andrew H. Kaye, Kerrie Clarke, Howard Geldard, Michael D. Green, Carole Alt, Jane Bartlett, Denis J. Morgan, Darryl W. Maher
Publikováno v:
Journal of Clinical Oncology. 16:2181-2187
PURPOSE To determine the recommended dose, toxicity profile, and pharmacokinetics of KRN8602 (MX2-hydrochloride), a novel morpholino anthracycline with potent cytotoxicity against anthracycline-sensitive and resistant experimental tumors in vitro and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eec3023ce683f1c25fa66617657d68e
https://doi.org/10.1200/jco.1998.16.6.2181
https://doi.org/10.1200/jco.1998.16.6.2181
Autor:
Jonathan Cebon, Howard Geldard, Denis J. Morgan, Kerrie Clarke, Darryl W. Maher, John S. Hill, Andrew H. Kaye, Michael D. Green, Russell L. Basser, Samantha J Park, Stan S. Stylli
Publikováno v:
Cancer Chemotherapy and Pharmacology. 41:423-426
Purpose: To investigate the effect of granulocyte colony-stimulating factor (G-CSF) on the pharmacokinetics and pharmacodynamics of the new morpholino anthracycline drug MX2. Methods: A total of 25 patients with advanced malignant disease participate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78ebd9780b5520137cff524273dc3608
https://doi.org/10.1007/s002800050761
https://doi.org/10.1007/s002800050761
Autor:
Kerrie Clarke, Jonathan Cebon, Samantha J Park, John S. Hill, Andrew H. Kaye, Michael D. Green, Darryl W. Maher, Stan S. Stylli, Russell L. Basser, Denis J. Morgan, Howard Geldard
Publikováno v:
Cancer Chemotherapy and Pharmacology. 40:202-208
The purpose of the present study was to investigate the pharmacokinetics and pharmacodynamics of the new morpholino anthracycline drug MX2. A total of 27 patients with advanced cancer participated in a dose-escalation study in the first cycle of trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8302c2ff97fcfdb60664c8a0bc326ea2
https://doi.org/10.1007/s002800050647
https://doi.org/10.1007/s002800050647
Autor:
Katherine M McGrath, Darryl W. Maher, Sue Houghton, Andrew Grigg, Andrew W. Boyd, Judith E. Layton, Heike Raunow, Andrew W. Roberts
Publikováno v:
Blood. 86:4437-4445
To define an optimal regimen for mobilizing and collecting peripheral blood progenitor cells (PBPC) for use in allogeneic transplantation, we evaluated the kinetics of mobilization by filgrastim (recombinant met- human granulocyte colony-stimulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1ed7c739951234fde88dfdebb3e853c
https://doi.org/10.1182/blood.v86.12.4437.bloodjournal86124437
https://doi.org/10.1182/blood.v86.12.4437.bloodjournal86124437
Autor:
Jonathan Cebon, Vincent Sinickas, John A. M. Gall, Donald Metcalf, George Hodgson, Darryl W. Maher, Dianne Grail, Graham J. Lieschke, Edouard G. Stanley, Ashley R. Dunn
Publikováno v:
Proceedings of the National Academy of Sciences. 91:5592-5596
Mice homozygous for a disrupted granulocyte/macrophage colony-stimulating factor (GM-CSF) gene develop normally and show no major perturbation of hematopoiesis up to 12 weeks of age. While most GM-CSF-deficient mice are superficially healthy and fert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff05bf2c0a67df2c7c30335a5918d55
https://doi.org/10.1073/pnas.91.12.5592
https://doi.org/10.1073/pnas.91.12.5592
Publikováno v:
British Journal of Haematology. 86:265-274
Haemopoietic growth factors (HGFs) are being administered to patients with neutropenic fever; however, little is known about the endogenous HGF response in these patients. Specific assays were used to study four HGFs, granulocyte (G-) CSF, granulocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3858708ea3734c5af3fa94b11f33e2a
https://doi.org/10.1111/j.1365-2141.1994.tb04725.x
https://doi.org/10.1111/j.1365-2141.1994.tb04725.x